This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting ...
A growing body of evidence suggests a margin safety for TRT in hypogonadal men with treated PCa. Several studies have demonstrated symptomatic improvement in hypogonadism without the development of ...
Low testosterone levels may increase the risk of higher-grade progression in prostate cancer patients under active surveillance, a retrospective cohort study suggested. Among over 900 patients, low ...
CHICAGO—Metastasis-free survival or overall survival may be a more reliable and meaningful clinical endpoint than PSA relapse in studies of prostate cancer (PCa) patients treated with androgen ...
SAN ANTONIO — A small pilot study delivered a big message about the use of testosterone in men with advanced or metastatic prostate cancer, according to a "Best Abstract" presented at the Sexual ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to ...
SAN ANTONIO -- More than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed biochemical recurrence after receiving postoperative apalutamide (Erleada) and androgen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results